Patel, Sapna P.
Kim, Dae Won
Bassett, Roland L.
Cain, Suzanne
Washington, Edwina
Hwu, Wen-Jen
Kim, Kevin B.
Papadopoulos, Nicholas E.
Homsi, Jade
Hwu, Patrick
Bedikian, Agop Y.
Funding for this research was provided by:
Bristol-Myers Squibb
National Cancer Institute (P30CA016672)
Article History
Received: 26 October 2016
Accepted: 8 June 2017
First Online: 13 June 2017
Compliance with ethical standards
:
: The clinical trial was funded by Bristol-Myers Squibb and the work supported by the MD Anderson Cancer Center Support Grant P30CA016672.
: Dr. Patel reports clinical trial support from Bristol-Myers Squibb for conduct of the study; non-promotional speakers fees from Bristol-Myers Squibb Mexico, non-promotional speakers fees from Merck & Co, advisory board honoraria from Castle Biosciences, Amgen and Genentech, and clinical trial support from Novartis, Glaxo SmithKline, Reata, and Deciphera outside the submitted work. Dr. WJ Hwu reports clinical trial support from Bristol-Myers Squibb, Merck, Glaxo SmithKline, and Medimmune outside the submitted work. Dr. KB Kim reports clinical trial funding and speakers fees from Bristol-Myers Squibb outside the submitted work. Dr. P Hwu is an advisory board member for Lion Biotechnologies and Immatics. All the other authors declare that they have no conflict of interest.